Forum Logikmemorial

Comment fonctionne notre forum => Accueil => Discussion démarrée par: globans12 le Janvier 07, 2026, 02:26:13 am

Titre: Is there a risk of developing a secondary blood cancer?
Posté par: globans12 le Janvier 07, 2026, 02:26:13 am

Yes, Niranib 100mg capsule (https://www.globanspharma.com/products/niranib-100mg-capsule) carries a risk of Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia (AML). These are serious bone marrow conditions that can develop during or after treatment. Visit Globans Pharma to know more about the medicine.